Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEPAFENAC for Posterior capsule opacification: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 62 adverse event reports in the FDA FAERS database where NEPAFENAC was used for Posterior capsule opacification.

Most Reported Side Effects for NEPAFENAC

Side Effect Reports % Deaths Hosp.
Eye pain 393 22.3% 1 4
Drug ineffective 270 15.3% 0 1
Treatment failure 208 11.8% 0 0
Vision blurred 133 7.6% 0 6
Eye irritation 67 3.8% 0 0
Visual impairment 66 3.8% 1 2
Product quality issue 57 3.2% 0 0
Liquid product physical issue 55 3.1% 0 0
Off label use 43 2.4% 0 5
Cystoid macular oedema 42 2.4% 0 1
Ocular hyperaemia 42 2.4% 1 1
Cataract 36 2.0% 0 11
Incorrect dose administered 35 2.0% 0 0
Ulcerative keratitis 35 2.0% 1 2
Visual acuity reduced 35 2.0% 1 1

Other Indications for NEPAFENAC

Product used for unknown indication (1,130) Cataract operation (183) Postoperative care (151) Preoperative care (34) Macular oedema (27) Cystoid macular oedema (23) Cataract (15) Inflammation (12) Eye pain (10) Eye inflammation (8)

Other Drugs Used for Posterior capsule opacification

DIFLUPREDNATE (157) PREDNISOLONE (21)

Related Pages

NEPAFENAC Full Profile All Posterior capsule opacification Drugs NEPAFENAC Demographics NEPAFENAC Timeline